Glycomimetics Stock Price on May 1, 2024
| GLYC Stock | USD 0.32 0.03 10.34% |
Below is the normalized historical share price chart for GlycoMimetics extending back to January 10, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GlycoMimetics stands at 0.32, as last reported on the 26th of November, with the highest price reaching 0.34 and the lowest price hitting 0.29 during the day.
If you're considering investing in GlycoMimetics Stock, it is important to understand the factors that can impact its price. GlycoMimetics is out of control given 3 months investment horizon. GlycoMimetics holds Efficiency (Sharpe) Ratio of 0.0999, which attests that the entity had a 0.0999% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.42% are justified by taking the suggested risk. Use GlycoMimetics Risk Adjusted Performance of 0.0746, downside deviation of 7.27, and Market Risk Adjusted Performance of (0.84) to evaluate company specific risk that cannot be diversified away.
At present, GlycoMimetics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 3.6 M, whereas Total Stockholder Equity is forecasted to decline to about 36.5 M. . At present, GlycoMimetics' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to about 15.7 K, whereas Price Earnings Ratio is forecasted to decline to (4.25). GlycoMimetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of January 2014 | 200 Day MA 0.9463 | 50 Day MA 0.251 | Beta 1.842 |
GlycoMimetics |
Sharpe Ratio = 0.0999
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | GLYC | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 24.18 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.42 actual daily | 48 52% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average GlycoMimetics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlycoMimetics by adding it to a well-diversified portfolio.
Price Book 1.7957 | Enterprise Value Ebitda (0.48) | Price Sales 1.9 K | Shares Float 42.5 M | Wall Street Target Price 1 |
GlycoMimetics Main Headline on 1st of May 2024
Acquisition by Junius Daniel M of 40000 shares of GlycoMimet... by Junius Daniel M
Filed transaction by GlycoMimetics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
GlycoMimetics Valuation on May 1, 2024
It is possible to determine the worth of GlycoMimetics on a given historical date. On May 1, 2024 GlycoMimetics was worth 1.8 at the beginning of the trading date compared to the closed value of 1.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GlycoMimetics stock. Still, in general, we apply an absolute valuation method to find GlycoMimetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GlycoMimetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GlycoMimetics' related companies.
| Open | High | Low | Close | Volume | |
| 1.56 | 1.90 | 1.51 | 1.80 | 1,450,313 | |
05/01/2024 | 1.80 | 1.93 | 1.62 | 1.62 | 982,228 |
| 1.68 | 1.78 | 1.67 | 1.72 | 858,550 |
| Backtest GlycoMimetics | | | GlycoMimetics History | | | GlycoMimetics Valuation | Previous | Next |
GlycoMimetics Trading Date Momentum on May 1, 2024
| On May 02 2024 GlycoMimetics was traded for 1.72 at the closing time. The top price for the day was 1.78 and the lowest listed price was 1.67 . The trading volume for the day was 858.5 K. The trading history from May 2, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 6.17% . The overall trading delta against the current closing price is 82.72% . |
GlycoMimetics Fundamentals Correlations and Trends
By evaluating GlycoMimetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GlycoMimetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GlycoMimetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About GlycoMimetics Stock history
GlycoMimetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlycoMimetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlycoMimetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlycoMimetics stock prices may prove useful in developing a viable investing in GlycoMimetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 63.3 M | 32.9 M | |
| Net Loss | -42 M | -44.1 M |
GlycoMimetics Quarterly Net Working Capital |
|
GlycoMimetics Stock Technical Analysis
GlycoMimetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
GlycoMimetics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
GlycoMimetics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
GlycoMimetics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how GlycoMimetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlycoMimetics shares will generate the highest return on investment. By undertsting and applying GlycoMimetics stock market strength indicators, traders can identify GlycoMimetics entry and exit signals to maximize returns
GlycoMimetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for GlycoMimetics' price direction in advance. Along with the technical and fundamental analysis of GlycoMimetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GlycoMimetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0746 | |||
| Jensen Alpha | 2.29 | |||
| Total Risk Alpha | (1.69) | |||
| Sortino Ratio | 0.2605 | |||
| Treynor Ratio | (0.85) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for GlycoMimetics Stock analysis
When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |